Comparative statistics by cancer registry

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Singapore, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison

			%		No. of excluded cases					Included cases
Site	ICD-10	Total registered	HV	DCO	DCO	No. follow-up	Others	Total	%	No.	%
C01-02	Tongue	124	100.0	0.0	0	4	0	4	3.2	120	96.8
C03-06	Oral cavity	138	97.8	0.0	0	3	0	3	2.2	135	97.8
C07-08	Salivary gland	95	98.9	0.0	0	2	6	8	8.4	87	91.6
C09	Tonsil	40	97.5	0.0	0	2	0	2	5.0	38	95.0
C11	Nasopharynx	1459	98.8	0.0	0	53	2	55	3.8	1404	96.2
C12-13	Hypopharynx	92	98.9	0.0	0	2	0	2	2.2	90	97.8
C15	Oesophagus	459	92.4	1.5	7	5	1	13	2.8	446	97.2
C16	Stomach	2191	94.0	1.1	25	41	25	91	4.2	2100	95.8
C17	Small intestine	88	94.3	0.0	0	3	5	8	9.1	80	90.9
C18	Colon	2628	93.3	0.8	20	79	28	127	4.8	2501	95.2
C19-20	Rectum	1831	97.2	0.2	3	66	9	78	4.3	1753	95.7
C21	Anus	53	98.1	0.0	0	0	0	0	0.0	53	100.0
C22	Liver	1655	26.8	5.2	86	19	0	105	6.3	1550	93.7
C23-24	Gall bladder	299	73.9	1.7	5	5	0	10	3.3	289	96.7
C25	Pancreas	536	41.8	3.4	18	3	3	24	4.5	512	95.5
C30-31	Nose/Sinuses	73	98.6	0.0	0	1	1	2	2.7	71	97.3
C32	Larynx	326	96.9	0.0	0	14	1	15	4.6	311	95.4
C33-34	Lung	4386	82.4	1.7	74	56	3	133	3.0	4253	97.0
C37-38	Other thoracic organs	65	89.2	1.5	1	1	0	2	3.1	63	96.9
C40-41	Bone	80	96.3	1.3	1	2	16	19	23.8	61	76.3
C43	Melanoma skin	66	100.0	0.0	0	6	0	6	9.1	60	90.9
C44	Other skin	1163	99.5	0.1	1	124	1	126	10.8	1037	89.2
C45	Mesothelioma	34	100.0	0.0	0	0	0	0	0.0	34	100.0
C47+C49	Connective tissue	185	94.6	1.1	2	7	10	19	10.3	166	89.7
C48	Peritoneum	44	86.4	0.0	0	1	3	4	9.1	40	90.9
C50	Breast	3395	98.9	0.2	7	147	37	191	5.6	3204	94.4
C51	Vulva	38	100.0	0.0	0	3	0	3	7.9	35	92.1
C53	Cervix	1037	98.7	0.3	3	50	0	53	5.1	984	94.9
C54	Corpus uteri	532	97.7	1.1	6	32	11	49	9.2	483	90.8
C56	Ovary	787	96.6	0.6	5	35	29	69	8.8	718	91.2
C60	Penis	42	100.0	0.0	0	1	0	1	2.4	41	97.6
C61	Prostate	796	95.1	0.5	4	39	1	44	5.5	752	94.5
C62	Testis	87	95.4	0.0	0	6	6	12	13.8	75	86.2
C64	Kidney	387	81.7	1.3	5	12	1	18	4.7	369	95.3
C65	Renal pelvis	45	95.6	0.0	0	1	0	1	2.2	44	97.8
C67	Urinary bladder	520	96.2	0.0	0	20	4	24	4.6	496	95.4
C70-72	Brain & nervous system	314	81.5	4.1	13	3	8	24	7.6	290	92.4
C73	Thyroid	588	97.6	0.0	0	33	1	34	5.8	554	94.2
C74	Adrenal gland	32	81.3	3.1	1	1	2	4	12.5	28	87.5
C81	Hodgkin lymphoma	79	100.0	0.0	0	6	0	6	7.6	73	92.4
C82-85+C96	Non-Hodgkin lymphoma	834	100.0	0.7	6	38	0	44	5.3	790	94.7
C90	Multiple myeloma	167	100.0	3.6	6	2	0	8	4.8	159	95.2
C91	Lymphoid leukaemia	209	100.0	0.5	1	3	0	4	1.9	205	98.1
C92-94	Myeloid leukaemia	408	100.0	0.7	3	15	0	18	4.4	390	95.6
C95	Leukaemia unspecified	80	100.0	7.5	6	2	0	8	10.0	72	90.0

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b:	Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)

Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site